120 related articles for article (PubMed ID: 16318991)
1. Immunomodulatory strategies for celiac disease.
Rossi M; Maurano F; Luongo D
Int Rev Immunol; 2005; 24(5-6):479-99. PubMed ID: 16318991
[TBL] [Abstract][Full Text] [Related]
2. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
3. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
4. Gliadin as a stimulator of innate responses in celiac disease.
Londei M; Ciacci C; Ricciardelli I; Vacca L; Quaratino S; Maiuri L
Mol Immunol; 2005 May; 42(8):913-8. PubMed ID: 15829281
[TBL] [Abstract][Full Text] [Related]
5. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease.
Henderson KN; Tye-Din JA; Reid HH; Chen Z; Borg NA; Beissbarth T; Tatham A; Mannering SI; Purcell AW; Dudek NL; van Heel DA; McCluskey J; Rossjohn J; Anderson RP
Immunity; 2007 Jul; 27(1):23-34. PubMed ID: 17629515
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.
Huibregtse IL; Marietta EV; Rashtak S; Koning F; Rottiers P; David CS; van Deventer SJ; Murray JA
J Immunol; 2009 Aug; 183(4):2390-6. PubMed ID: 19635921
[TBL] [Abstract][Full Text] [Related]
7. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.
Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
9. Celiac disease--sandwiched between innate and adaptive immunity.
Stepniak D; Koning F
Hum Immunol; 2006 Jun; 67(6):460-8. PubMed ID: 16728270
[TBL] [Abstract][Full Text] [Related]
10. Coeliac disease.
Periolo N; Cherñavsky AC
Autoimmun Rev; 2006 Mar; 5(3):202-8. PubMed ID: 16483920
[TBL] [Abstract][Full Text] [Related]
11. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
12. [Celiac disease in 2009: a future without gluten-free diet?].
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Gastroenterol Clin Biol; 2009; 33(8-9):635-47. PubMed ID: 19682814
[TBL] [Abstract][Full Text] [Related]
13. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
[TBL] [Abstract][Full Text] [Related]
14. Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohn's disease.
James SP
J Allergy Clin Immunol; 2005 Jan; 115(1):25-30. PubMed ID: 15637543
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients.
Diosdado B; Wijmenga C
Expert Rev Mol Diagn; 2005 Sep; 5(5):681-700. PubMed ID: 16149872
[TBL] [Abstract][Full Text] [Related]
16. The immunologic basis for celiac disease and related disorders.
Braegger CP; MacDonald TT
Semin Gastrointest Dis; 1996 Jul; 7(3):124-33. PubMed ID: 8817764
[TBL] [Abstract][Full Text] [Related]
17. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity induced by gliadin-presenting spores of Bacillus subtilis in HLA-DQ8-transgenic mice.
Bonavita R; Isticato R; Maurano F; Ricca E; Rossi M
Immunol Lett; 2015 Jun; 165(2):84-9. PubMed ID: 25944582
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity.
D'Arienzo R; Maurano F; Lavermicocca P; Ricca E; Rossi M
Cytokine; 2009 Dec; 48(3):254-9. PubMed ID: 19736022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
